“…The overall functional capacities of human infant T cells as being skewed toward Th2 or antiinflammatory responses (8) is largely derived from studies of umbilical cord blood (24)(25)(26). Measuring the in vivo infant immune response to VRTI has been more challenging, and has involved characterization of cells and cytokines in peripheral blood (6,21,27,28), nasopharyngeal washes (29,30), or tracheal aspirates (31,32). However, sampling remains limited, and unifying immune parameters related to disease outcome and severity has not emerged.…”